These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 26628402

  • 1. Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson's disease and after chronic pramipexole treatment.
    Berghauzen-Maciejewska K, Wardas J, Kosmowska B, Domin H, Śmiałowska M, Głowacka U, Ossowska K.
    Neuroscience; 2016 Feb 09; 314():22-34. PubMed ID: 26628402
    [Abstract] [Full Text] [Related]

  • 2. Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.
    Berghauzen-Maciejewska K, Wardas J, Kosmowska B, Głowacka U, Kuter K, Ossowska K.
    PLoS One; 2015 Feb 09; 10(3):e0117698. PubMed ID: 25739024
    [Abstract] [Full Text] [Related]

  • 3. Pramipexole but not imipramine or fluoxetine reverses the "depressive-like" behaviour in a rat model of preclinical stages of Parkinson's disease.
    Berghauzen-Maciejewska K, Kuter K, Kolasiewicz W, Głowacka U, Dziubina A, Ossowska K, Wardas J.
    Behav Brain Res; 2014 Sep 01; 271():343-53. PubMed ID: 24956561
    [Abstract] [Full Text] [Related]

  • 4. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH, Fabricius K, Barkholt P, Mikkelsen JD, Jelsing J, Pyke C, Knudsen LB, Vrang N.
    Brain Res; 2016 Sep 01; 1646():354-365. PubMed ID: 27233809
    [Abstract] [Full Text] [Related]

  • 5. Serotonin hyperinnervation of the striatum with high synaptic incidence in parkinsonian monkeys.
    Gagnon D, Gregoire L, Di Paolo T, Parent M.
    Brain Struct Funct; 2016 Sep 01; 221(7):3675-91. PubMed ID: 26462663
    [Abstract] [Full Text] [Related]

  • 6. In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease.
    Casteels C, Lauwers E, Baitar A, Bormans G, Baekelandt V, Van Laere K.
    Brain Res; 2010 Feb 26; 1316():153-62. PubMed ID: 20026090
    [Abstract] [Full Text] [Related]

  • 7. Interactions of the tricyclic antidepressant drug amitriptyline with L-DOPA in the striatum and substantia nigra of unilaterally 6-OHDA-lesioned rats. Relevance to motor dysfunction in Parkinson's disease.
    Kamińska K, Lenda T, Konieczny J, Wardas J, Lorenc-Koci E.
    Neurochem Int; 2018 Dec 26; 121():125-139. PubMed ID: 30290201
    [Abstract] [Full Text] [Related]

  • 8. Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys.
    Sánchez MG, Morissette M, Di Paolo T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug 01; 45():170-7. PubMed ID: 23719069
    [Abstract] [Full Text] [Related]

  • 9. Lesions of the lateral habenula excite dopamine neurons in the ventral tegmental area and serotonin neurons in the dorsal raphe nuclei in hemiparkinsonian rats.
    Tan H, Du C, Zhang L, Guo Y, Yang Y, Sun Q, Zhang Q, Li L.
    Brain Res; 2024 Jul 15; 1835():148918. PubMed ID: 38588847
    [Abstract] [Full Text] [Related]

  • 10. Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
    Conti MM, Meadows SM, Melikhov-Sosin M, Lindenbach D, Hallmark J, Werner DF, Bishop C.
    Neuropharmacology; 2016 Nov 15; 110(Pt A):125-134. PubMed ID: 27452719
    [Abstract] [Full Text] [Related]

  • 11. Serotonergic and dopaminergic neurons in the dorsal raphe are differentially altered in a mouse model for parkinsonism.
    Boi L, Johansson Y, Tonini R, Moratalla R, Fisone G, Silberberg G.
    Elife; 2024 Jun 28; 12():. PubMed ID: 38940422
    [Abstract] [Full Text] [Related]

  • 12. 6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging.
    Kondoh T, Bannai M, Nishino H, Torii K.
    Exp Neurol; 2005 Mar 28; 192(1):194-202. PubMed ID: 15698634
    [Abstract] [Full Text] [Related]

  • 13. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK, Shukla S, Seth K, Chauhan S, Sinha C, Shukla Y, Agrawal AK.
    Neurobiol Dis; 2006 May 28; 22(2):421-34. PubMed ID: 16480889
    [Abstract] [Full Text] [Related]

  • 14. Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.
    Cheshire P, Ayton S, Bertram KL, Ling H, Li A, McLean C, Halliday GM, O'Sullivan SS, Revesz T, Finkelstein DI, Storey E, Williams DR.
    Mov Disord; 2015 May 28; 30(6):796-804. PubMed ID: 25649148
    [Abstract] [Full Text] [Related]

  • 15. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
    Pellegrino D, Cicchetti F, Wang X, Zhu A, Yu M, Saint-Pierre M, Brownell AL.
    J Nucl Med; 2007 Jul 28; 48(7):1147-53. PubMed ID: 17574972
    [Abstract] [Full Text] [Related]

  • 16. Blockade of calcium-permeable AMPA receptors in the lateral habenula produces increased antidepressant-like effects in unilateral 6-hydroxydopamine-lesioned rats compared to sham-lesioned rats.
    Zhang J, Wang Y, Sun YN, Li LB, Zhang L, Guo Y, Wang T, Yao L, Chen L, Liu J.
    Neuropharmacology; 2019 Oct 28; 157():107687. PubMed ID: 31251995
    [Abstract] [Full Text] [Related]

  • 17. Adaptive gene expression changes on the healthy side of parkinsonian rats.
    Capper-Loup C, Frey CM, Rebell D, Kaelin-Lang A.
    Neuroscience; 2013 Mar 13; 233():157-65. PubMed ID: 23270858
    [Abstract] [Full Text] [Related]

  • 18. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
    Joyce JN, Woolsey C, Ryoo H, Borwege S, Hagner D.
    BMC Biol; 2004 Oct 11; 2():22. PubMed ID: 15473914
    [Abstract] [Full Text] [Related]

  • 19. Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat.
    Shepard JD, Chuang DT, Shaham Y, Morales M.
    Psychopharmacology (Berl); 2006 May 11; 185(4):505-13. PubMed ID: 16555063
    [Abstract] [Full Text] [Related]

  • 20. PET Imaging of Serotonin Transporters With 4-[(18)F]-ADAM in a Parkinsonian Rat Model With Porcine Neural Xenografts.
    Chiu CH, Li IH, Weng SJ, Huang YS, Wu SC, Chou TK, Huang WS, Liao MH, Shiue CY, Cheng CY, Ma KH.
    Cell Transplant; 2016 May 11; 25(2):301-11. PubMed ID: 25994923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.